BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Xiang S, Li J, Shen J, Zhao Y, Wu X, Li M, Yang X, Kaboli PJ, Du F, Zheng Y, Wen Q, Cho CH, Yi T, Xiao Z. Identification of Prognostic Genes in the Tumor Microenvironment of Hepatocellular Carcinoma. Front Immunol 2021;12:653836. [PMID: 33897701 DOI: 10.3389/fimmu.2021.653836] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Yang B, Chen X, Zhang W, Zou L. Highly immune-related genes of breast cancer: potential diagnostic and prognostic biomarkers.. [DOI: 10.21203/rs.3.rs-2326101/v1] [Reference Citation Analysis]
2 Xia Y, Zhou L, Yang H, Yu C. Chemokine CCL5 immune subtypes of human liver cancer with prognostic significance. International Immunopharmacology 2022;113:109372. [DOI: 10.1016/j.intimp.2022.109372] [Reference Citation Analysis]
3 Ding W, Zhang Z, Ye N, Zhuang L, Yuan Z, Xue W, Tan Y, Xu X, Liu Y. Identification of Key Genes in the HBV-Related HCC Immune Microenvironment Using Integrated Bioinformatics Analysis. Journal of Oncology 2022;2022:1-15. [DOI: 10.1155/2022/2797033] [Reference Citation Analysis]
4 Li X, Song D, Su S, He X, Cao F, Yang C, Li K, Huang S, Li C, Wang C, Zhang A, Pang P, Zheng Y. Critical role of guanylate binding protein 5 in tumor immune microenvironment and predictive value of immunotherapy response. Front Genet 2022;13:984615. [DOI: 10.3389/fgene.2022.984615] [Reference Citation Analysis]
5 Xu H, Chen X, Niu X, Pu J. CCDC103: A Novel Biomarker with Potential Prognostic in Glioma.. [DOI: 10.21203/rs.3.rs-2026652/v1] [Reference Citation Analysis]
6 Xu H, Chen X, Niu X, Pu J. Zinc finger DHHC-type palmitoyltransferase 12 is a potential prognostic biomarker in glioma.. [DOI: 10.21203/rs.3.rs-2006847/v1] [Reference Citation Analysis]
7 Su Q, Zhang S, Ran J. Identification of a Novel PPAR Signature for Predicting Prognosis and Immune Microenvironment in Hepatocellular Carcinoma.. [DOI: 10.21203/rs.3.rs-1943906/v1] [Reference Citation Analysis]
8 Ding F, Li J, Zhang Y, Wang C, Yu Y, Isaguliants M. Identifying a Novel Endoplasmic Reticulum-Related Prognostic Model for Hepatocellular Carcinomas. Oxidative Medicine and Cellular Longevity 2022;2022:1-24. [DOI: 10.1155/2022/8248355] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Jing W, Peng R, Li X, Lv S, Duan Y, Jiang S, Wang F. Study on the Prognostic Values of TTC36 Correlated with Immune Infiltrates and Its Methylation in Hepatocellular Carcinoma. Journal of Immunology Research 2022;2022:1-15. [DOI: 10.1155/2022/7267131] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Fu J, Qin W, Tong Q, Li Z, Shao Y, Liu Z, Liu C, Wang Z, Xu X. A novel DNA methylation-driver gene signature for long-term survival prediction of hepatitis-positive hepatocellular carcinoma patients. Cancer Med 2022;11:4721-35. [PMID: 35637633 DOI: 10.1002/cam4.4838] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Zhao Y, Wu J, Li L, Zhang H, Zhang H, Li J, Zhong H, Lei T, Jin Y, Xu B, Song Q. Guanylate-Binding Protein 1 as a Potential Predictor of Immunotherapy: A Pan-Cancer Analysis. Front Genet 2022;13:820135. [DOI: 10.3389/fgene.2022.820135] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Zhao Z, Wang C, Chu P, Lu X. Key Genes Associated with Tumor-Infiltrating Non-regulatory CD4- and CD8-Positive T Cells in Microenvironment of Hepatocellular Carcinoma. Biochem Genet. [DOI: 10.1007/s10528-021-10175-3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Huang S, Zhang J, Lai X, Zhuang L, Wu J. Identification of Novel Tumor Microenvironment-Related Long Noncoding RNAs to Determine the Prognosis and Response to Immunotherapy of Hepatocellular Carcinoma Patients. Front Mol Biosci 2021;8:781307. [PMID: 35004851 DOI: 10.3389/fmolb.2021.781307] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
14 Wang H, Lu L, Liang X, Chen Y. Identification of prognostic genes in the pancreatic adenocarcinoma immune microenvironment by integrated bioinformatics analysis. Cancer Immunol Immunother 2021. [PMID: 34854950 DOI: 10.1007/s00262-021-03110-3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Yin S, Yang S, Luo Y, Lu J, Hu G, Wang K, Shao Y, Zhou S, Koo S, Qiu Y, Wang T, Yu H. Cyclin-dependent kinase 1 as a potential target for lycorine against hepatocellular carcinoma. Biochem Pharmacol 2021;193:114806. [PMID: 34673013 DOI: 10.1016/j.bcp.2021.114806] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
16 Zhou X, Lei S, Li L, Xu T, Gu W, Ma F, Yang R. [Peripheral blood EMR3 gene methylation level is correlated with breast cancer in Chinese women]. Nan Fang Yi Ke Da Xue Xue Bao 2021;41:1456-63. [PMID: 34755660 DOI: 10.12122/j.issn.1673-4254.2021.10.03] [Reference Citation Analysis]